Back to search
FDAFDA · Food and drugs·Recall number D-1063-2014

Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, NDC 0456-3407-33

Published February 12, 2014 · Recall initiated: November 13, 2013

Summary

FDA records drug Class III recall D-1063-2014, published February 12, 2014 and initiated November 13, 2013. Recalling firm: Forest Pharmaceuticals Inc; Status: Terminated; Reported quantity: 156 bottles; Lot: Lot 1111291 Exp. 02/16. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Forest Pharmaceuticals Inc
Distributor
Nationwide and Puerto Rico.
Lot
Lot 1111291 Exp. 02/16
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, NDC 0456-3407-33 recalled?

Yes. FDA published recall D-1063-2014 on February 12, 2014. Reported hazard: Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter